P615: Low rate of clinical follow-up for potential germline variants identified in hematologic malignancies with a next generation sequencing panel

P615: Low rate of clinical follow-up for potential germline variants identified in hematologic malignancies with a next generation sequencing panel

Bibliographic Details
Main Authors:	Hannah Wollenzien, Thomas Olson, Kelly Rafferty, Scott Turner, Andrea Ferreira-Gonzalez, Elizabeth Barrie
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Series:	Genetics in Medicine Open
Online Access:	http://www.sciencedirect.com/science/article/pii/S2949774424006678

Similar Items

P346: Somatic RUNX1 variants in hematologic malignancy: Could they be germline?
by: Kelly Wang, et al.
Published: (2023-01-01)

Germline and somatic drivers in inherited hematologic malignancies
by: Julian Zoller, et al.
Published: (2023-10-01)

P313: RECURRENT PATHOGENIC GERMLINE CHEK2 VARIANTS IN PEDIATRIC PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
by: T. Brozou, et al.
Published: (2022-06-01)

ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants
by: Xi Luo, et al.
Published: (2019-10-01)

How I curate: applying American Society of Hematology-Clinical Genome Resource Myeloid Malignancy Variant Curation Expert Panel rules for RUNX1 variant curation for germline predisposition to myeloid malignancies
by: David Wu, et al.
Published: (2020-04-01)

Investigation of germline variants in Bahraini women with breast cancer using next-generation sequencing based-multigene panel
by: Ghada Al-Kafaji, et al.
Published: (2023-01-01)

Validation and clinical application of a targeted next-generation sequencing gene panel for solid and hematologic malignancies
by: Iván Prieto-Potin, et al.
Published: (2020-10-01)

Resolving inherited and de novo germline predisposing sequence variants by means of whole exome trio analyses in childhood hematological malignancies
by: Triantafyllia Brozou, et al.
Published: (2023-02-01)

Histone Variants and Their Chaperones in Hematological Malignancies
by: Ecem Kirkiz, et al.
Published: (2023-08-01)

Germline Pathogenic Variants Identified by Targeted Next-Generation Sequencing of Susceptibility Genes in Pheochromocytoma and Paraganglioma
by: Sinem Yalcintepe, et al.
Published: (2021-03-01)

Advances in next-generation sequencing and emerging technologies for hematologic malignancies
by: Regina Kwon, et al.
Published: (2023-08-01)

Universal germline genetic testing in patients with hematologic malignancies using DNA isolated from nail clippings
by: Ozge Ceyhan-Birsoy, et al.
Published: (2024-04-01)

Germline and somatic variants in ovarian carcinoma: A next-generation sequencing (NGS) analysis
by: Angeliki Andrikopoulou, et al.
Published: (2022-12-01)

Algorithmic improvements for discovery of germline copy number variants in next-generation sequencing data
by: Brendan O’Fallon, et al.
Published: (2022-07-01)

Multi-omics approach identifies germline regulatory variants associated with hematopoietic malignancies in retriever dog breeds.
by: Jacquelyn M Evans, et al.
Published: (2021-05-01)

Metagenomic Next-Generation Sequencing for Diagnostically Challenging Mucormycosis in Patients with Hematological Malignancies
by: Zhang M, et al.
Published: (2022-12-01)

Performance evaluation of pipelines for mapping, variant calling and interval padding, for the analysis of NGS germline panels
by: Maria Zanti, et al.
Published: (2021-04-01)

P591: Examining likely-somatic variants in cancer susceptibility genes identified through germline multigene panel testing
by: Kate Loranger, et al.
Published: (2024-01-01)

Mucormycosis in Hematologic Malignancies: Clinical Follow-Up and Treatment Results
by: Nagehan Didem Sarı, et al.
Published: (2021-11-01)

Quality of life in higher resolution: the next generation of comparative effectiveness research in malignant hematology
by: Thomas W. LeBlanc, et al.
Published: (2013-06-01)

ADW 615 - ADVANCED BUSINESS STATISTICS APRIL 08.
by: PPP, Pusat Pengajian Pengurusan
Published: (2008)

AGW 615 - ADVANCED BUNISESS STATISTICS APRIL 08.
by: PPP, Pusat Pengajian Pengurusan
Published: (2008)

AGW615 - ADVANCED BUSINESS STATISTICS - FEBRUARI 1998.
by: PPP, Pusat Pengajian Pengurusan
Published: (1998)

AGW615 - Advanced Business Statistics - February 2000
by: PPP, Pusat Pengajian Pengurusan
Published: (2000)

Challenges associated with the identification of germline variants on myeloid malignancy genomic profiling—a Singaporean experience
by: Hui-Lin Chin, et al.
Published: (2023-10-01)

Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer
by: Teo, M, et al.
Published: (2014)

Germline Mutations Related to Primary Hyperparathyroidism Identified by Next-Generation Sequencing
by: Hye-Sun Park, et al.
Published: (2022-04-01)

Two-Time Multiplexed Targeted Next-Generation Sequencing Might Help the Implementation of Germline Screening Tools for Myelodysplastic Syndromes/Hematologic Neoplasms
by: Oriol Calvete, et al.
Published: (2023-12-01)

ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
by: Daniel Olson, et al.
Published: (2014-08-01)

The Need for a Consensus Next-generation Sequencing Panel for Mature Lymphoid Malignancies
by: Pierre Sujobert, et al.
Published: (2019-02-01)

Spectrum of germline pathogenic variants using a targeted next generation sequencing panel and genotype-phenotype correlations in patients with suspected hereditary breast cancer at an academic medical centre in Pakistan
by: Fizza Akbar, et al.
Published: (2022-06-01)

Measuring Clinical Benefit of Treatments for Hematologic Malignancies: Critical First Steps Accomplished—What is Next?
by: John G. Gribben, et al.
Published: (2020-04-01)

Clinical Application of Metagenomic Next-Generation Sequencing in Patients with Hematologic Malignancies Suffering from Sepsis
by: Wang-Da Liu, et al.
Published: (2021-11-01)

Metagenomic Next-Generation Sequencing Successfully Detects Pulmonary Infectious Pathogens in Children With Hematologic Malignancy
by: Dao Wang, et al.
Published: (2022-06-01)

Half of germline pathogenic and likely pathogenic variants found on panel tests do not fulfil NHS testing criteria
by: Tala Andoni, et al.
Published: (2022-02-01)

P718: Analytical validation of a comprehensive targeted DNA sequencing panel for hematologic malignancies
by: Ruoying Yu, et al.
Published: (2024-01-01)

Germline multigene panel testing in acute and chronic pancreatitis
by: Mitchell L. Ramsey, et al.
Published: (2024-01-01)

Germline multigene panel testing in acute and chronic pancreatitis.
by: Mitchell L Ramsey, et al.
Published: (2024-01-01)

Discussion - G. T. Houlsby (2004). Geotechnique 54, No. 10, 615
by: Dean, E, et al.
Published: (2005)

P079: A recurrent POT1 germline variant associated with early onset malignant melanoma, desmoid tumor and other malignancies
by: Aasem Abu Shtaya, et al.
Published: (2024-01-01)